LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.83 Consensus Target Price from Analysts

by · The Markets Daily

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) have been given an average rating of “Moderate Buy” by the nine analysts that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, five have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $8.8333.

Several analysts recently issued reports on LFST shares. BMO Capital Markets began coverage on LifeStance Health Group in a report on Thursday, November 13th. They set an “outperform” rating and a $8.00 price objective for the company. Zacks Research lowered LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 5th. Barclays initiated coverage on LifeStance Health Group in a report on Tuesday, December 9th. They set an “overweight” rating and a $8.00 price target for the company. Weiss Ratings reissued a “sell (d-)” rating on shares of LifeStance Health Group in a research note on Monday, December 29th. Finally, Wall Street Zen lowered shares of LifeStance Health Group from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th.

Read Our Latest Analysis on LifeStance Health Group

Insider Transactions at LifeStance Health Group

In other LifeStance Health Group news, Director Robert Bessler sold 119,942 shares of the stock in a transaction on Friday, December 19th. The shares were sold at an average price of $7.04, for a total transaction of $844,391.68. Following the transaction, the director directly owned 1,318,983 shares of the company’s stock, valued at $9,285,640.32. This represents a 8.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Ann Varanakis sold 50,000 shares of the firm’s stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $6.90, for a total value of $345,000.00. Following the transaction, the insider owned 315,610 shares in the company, valued at approximately $2,177,709. This trade represents a 13.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 327,326 shares of company stock worth $2,259,317 in the last 90 days. 6.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Park Edge Advisors LLC bought a new position in shares of LifeStance Health Group in the 2nd quarter valued at approximately $52,000. Bayesian Capital Management LP acquired a new position in LifeStance Health Group during the second quarter valued at approximately $52,000. Blair William & Co. IL bought a new position in shares of LifeStance Health Group in the second quarter valued at approximately $70,000. Public Employees Retirement System of Ohio bought a new position in shares of LifeStance Health Group in the second quarter valued at approximately $70,000. Finally, Vanguard Personalized Indexing Management LLC acquired a new stake in shares of LifeStance Health Group in the third quarter worth $72,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Stock Performance

LFST stock opened at $7.05 on Friday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.58 and a current ratio of 1.58. The stock has a market cap of $2.74 billion, a P/E ratio of -235.00 and a beta of 1.12. The firm has a 50 day simple moving average of $6.42 and a 200 day simple moving average of $5.49. LifeStance Health Group has a 52 week low of $3.74 and a 52 week high of $8.30.

LifeStance Health Group (NASDAQ:LFST – Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.03. The firm had revenue of $363.81 million for the quarter, compared to analyst estimates of $355.06 million. LifeStance Health Group had a negative net margin of 0.67% and a negative return on equity of 0.62%. The company’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.02) EPS. Research analysts anticipate that LifeStance Health Group will post -0.18 earnings per share for the current fiscal year.

About LifeStance Health Group

(Get Free Report)

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.

Recommended Stories